Literature DB >> 35658247

Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing.

D Scuteri1, M Contrada2, T Loria3, D Sturino4, A Cerasa5, P Tonin6, G Sandrini7, S Tamburin8, A C Bruni9, P Nicotera10, M T Corasaniti11, G Bagetta12.   

Abstract

The 97% of dementia patients develops fluctuant neuropsychiatric symptoms often related to under-diagnosed and unrelieved pain. Up to 80% severe demented nursing home residents experiences chronic pain due to age-related comorbidities. Patients lacking self-report skills risk not to be appropriately treated for pain. Mobilization-Observation-Behavior-Intensity-Dementia (MOBID2) is the sole pain scale to consider the frequent co-occurrence of musculoskeletal and visceral pain and to unravel concealed pain through active guided movements. Accordingly, the Italian real-world setting can benefit from its translation and validation. This clinical study provides a translated, adapted and validated version of the MOBID2, the Italian I-MOBID2. The translation, adaptation and validation of the scale for non-verbal, severe demented patients was conducted according to current guidelines in a cohort of 11 patients over 65 with mini-mental state examination ≤ 12. The I-MOBID2 proves: good face and scale content validity index (0.89); reliable internal consistency (Cronbach's α = 0.751); good to excellent inter-rater (Intraclass correlation coefficient, and test-retest (ICC = 0.902) reliability. The construct validity is high (Rho = 0.748 p < 0.05 for 11 patients, Spearman rank order correlation of the overall pain intensity score with the maximum item score of I-MOBID2 Part 1; rho=0.895 p < 0.01 for 11 patients, for the overall pain intensity score with the maximum item score of I-MOBID2 Part 2) and a good rate of inter-rater and test-retest agreement was demonstrated by Cohen's K = 0.744. The average execution time is of 5.8 min, thus making I-MOBID2 a useful tool suitable also for future development in community setting with administration by caregivers.
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Dementia; I-MOBID2; Italian translation and validation; MOBID-2; Pain; Psychometric properties; Reliability; Validity

Mesh:

Year:  2022        PMID: 35658247     DOI: 10.1016/j.biopha.2022.113013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol.

Authors:  Damiana Scuteri; Marianna Contrada; Teresa Loria; Paolo Tonin; Giorgio Sandrini; Stefano Tamburin; Pierluigi Nicotera; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Brain Sci       Date:  2022-04-29

Review 2.  Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence.

Authors:  Damiana Scuteri; Francesca Guida; Serena Boccella; Enza Palazzo; Sabatino Maione; Juan Francisco Rodríguez-Landa; Lucia Martínez-Mota; Paolo Tonin; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

3.  Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia.

Authors:  Damiana Scuteri; Laura Rombolà; Takafumi Hayashi; Chizuko Watanabe; Shinobu Sakurada; Kengo Hamamura; Tsukasa Sakurada; Paolo Tonin; Giacinto Bagetta; Luigi A Morrone; Maria Tiziana Corasaniti
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.